Médisup Sciences Group acquires a majority stake in Take the Wind. Combined group creates leading global medical education and simulation provider.
The holding company of Médisup Sciences (“Médisup”), a leading French medical education company, is pleased to announce the acquisition of a majority stake in Take The Wind S.A (TTW).
Take The Wind is a Portuguese specialist technology leader in the virtual medical simulation market, serving medical, nursing, community colleges and high schools, scientific societies, hospitals, and pharmaceutical companies globally. The Company operates primarily under the Body Interact brand, which simulates real world scenarios with virtual patients via 700+ clinical cases, dynamically integrating multiple internal and external drivers of patients’ health conditions. The product is available in eight languages, and currently serves over 180,000 users in over 50countries.
Take the Wind was founded in 2008 by Teresa and Pedro Pinto, who will both retain a significant stake in the Company and will continue to lead its management team.
Arnaud Dreyfuss, founder and CEO of Médisup said, “We are delighted to partner with the Take the Wind team in the next phase of the business’s growth. Body Interact is the best-in-class operator providing exceptional levels of education that enables medical students and professionals to dramatically improve their clinical abilities in a cost-efficient way.”
Teresa Pinto, co-founder and COO of TTW added, “We are very excited to collaborate with Médisup, and foresee a strong cultural fit given the similar founder-led mentality. We express our profound gratitude to the whole TTW team, including its business partners and customers, for being part of the development of a game-changer product and a global company, which will consolidate its industry leadership and continue its high innovative performance in this new stage.”
As with Take The Wind, Médisup continues to be founder-led, following its 2021 sale of a majority stake to StirlingSquare Capital Partners, a leading pan-European mid-market private equity firm.
